Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Radiation Biology, Hypersensitivity Radiation Response

Kevin Camphausen

MD

🏢National Cancer Institute🌐USA

Chief, Radiation Oncology Branch

48
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Kevin Camphausen has investigated low-dose hypersensitivity and the underlying mechanisms of the hyper-radiosensitivity/increased radioresistance (HRS/IRR) response observed at low radiation doses. His laboratory has explored checkpoint kinase inhibitors as radiation sensitizers and contributed to early-phase trials of radiosensitizing agents at the NCI. His work bridges fundamental radiation biology to rational clinical trial design for novel radiation combinations.

Share:

🧪Research Fields 研究领域

radiation low-dose hypersensitivity
radiation HRS hyper-radiosensitivity
radiobiology G2 checkpoint
cancer radiation sensitizers
NCI radiation oncology clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Kevin Camphausen 的研究动态

Follow Kevin Camphausen's research updates

留下邮箱,当我们发布与 Kevin Camphausen(National Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment